<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04441983</url>
  </required_header>
  <id_info>
    <org_study_id>R449</org_study_id>
    <nct_id>NCT04441983</nct_id>
  </id_info>
  <brief_title>Foot/Ankle at 7T MRI</brief_title>
  <official_title>High-Resolution MR Imaging (7 Tesla) Findings of the Plantar Plate Compared With Current Clinical Standard Sequences (1.5 or 3 Tesla) and Surgical Reference Standard</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balgrist University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balgrist University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  To evaluate standard clinical sequences for 7 Tesla MRI of the foot and/or ankle to
           improve detailed depiction of the complex anatomy of this region.

        -  To evaluate various pathologies of the foot and/or ankle (plantar plate tears, Morton
           neuroma, tendon tears, ligament tears etc.).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sensitivity / specificity</measure>
    <time_frame>2 years</time_frame>
    <description>The sensitivity/specificity for detection of various pathologies in the foot/ankle, for exampleMorton neuroma, plantar plate tears and tendon injuries at 7T MRI</description>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Plantar Plate Tear</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>7 Tesla MRI of the foot</intervention_name>
    <description>7 Tesla MRI</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have undergone a forefoot MRI for clinical indications (or previous study)
        will be enrolled
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent as documented by signature (Appendix Informed Consent Form)

          -  at least 18 years old

          -  Study group: Patients with specific pathologies (i.e. Morton neuroma, tendon tears,
             plantar plate tears) as proven by 1,5 or 3T MRI or asymptomatic subjects (to look at
             the normal microanatomy of different structures, mainly the plantar plate)

          -  Control group: No evidence of the respective pathology.

        Exclusion Criteria:

          -  previous foot surgery with metal in vivo

          -  pregnancy or breast feeding

          -  any MRI contra-indications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christoph Germann, MD</last_name>
    <phone>+41443863322</phone>
    <email>christoph.germann@balgrist.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Balgrist University Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chrisotph Germann, MD</last_name>
      <phone>+41443863322</phone>
      <email>christoph.germann@balgrist.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 19, 2020</study_first_submitted>
  <study_first_submitted_qc>June 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2020</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Balgrist University Hospital</investigator_affiliation>
    <investigator_full_name>Reto Sutter</investigator_full_name>
    <investigator_title>head of radiology, medical doctor, principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

